Catalysts & Ligands

ZereneX offers a diverse set of over 3000 catalysts and ligands to enhance and facilitate in the utilisation and investigation of a variety of processes including asymmetric hydrogenation, C-C and C-X cross-coupling reactions as well as chiral transformations.

Top of page

Industry News

Entrants so far have come from Shire, Bayer, AbbVie, Eisai Europe, Novartis, GSK, MSD, Lundbeck, HFA Healthcare Products, Sandoz and...
Read More >

More Stories

News

Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >

More Stories

Latest Tweets

Follow Us